cadenas

ITCC-072 INFORM2 NivEnt

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-072 INFORM2 NivEnt

INFORM2 exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies

Promotor Name : KiTZ Heidelberg

Investigator Name : Olaf Witt